Brief: Inozyme Pharma Reports Q1 Loss Per Share Of $0.47
May 12 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA REPORTS Q1 2021 FINANCIAL RESULTS AND
PROVIDES
BUSINESS HIGHLIGHTS
* INOZYME PHARMA INC QUARTERLY LOSS PER SHARE $0.47
Source text for Eikon: ID:nGNXbRwbmS
Further company coverage: INZY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin